Bozidis Petros, Tsaousi Eleni T, Kostoulas Charilaos, Sakaloglou Prodromos, Gouni Athanasia, Koumpouli Despoina, Sakkas Hercules, Georgiou Ioannis, Gartzonika Konstantina
Department of Microbiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
Laboratory of Medical Genetics in Clinical Practice, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
Diagnostics (Basel). 2022 Apr 13;12(4):973. doi: 10.3390/diagnostics12040973.
Several SARS-CoV-2 variants have emerged and early detection for monitoring their prevalence is crucial. Many identification strategies have been implemented in cases where sequencing data for confirmation is pending or not available. The presence of B.1.1.318 among prevalent variants was indicated by an unusual amplification pattern in various RT-qPCR commercial assays. Positive samples for SARS-CoV-2, as determined using the Allplex SARS-CoV-2 Assay, the Viasure SARS-CoV-2 Real Time Detection Kit and the GeneFinder COVID-19 Plus RealAmp Kit, presented a delay or failure in the amplification of the N gene, which was further investigated. Whole-genome sequencing was used for variant characterization. The differences between the mean Ct values for amplification of the N gene vs. other genes were calculated for each detection system and found to be at least 14 cycles. Sequencing by WGS revealed that all the N gene dropout samples contained the B.1.1.318 variant. All the isolates harbored three non-synonymous mutations in the N gene, which resulted in four amino acid changes (R203K, G204R, A208G, Met234I). Although caution should be taken when the identification of SARS-CoV-2 variants is based on viral gene amplification failure, such patterns could serve as a basis for rapid and cost-effective screening, functioning as indicators of community circulation of specific variants, requiring subsequent verification via sequencing.
几种严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体已经出现,早期检测以监测它们的流行情况至关重要。在确认的测序数据悬而未决或无法获得的情况下,已经实施了许多鉴定策略。在各种逆转录定量聚合酶链反应(RT-qPCR)商业检测中,一种不寻常的扩增模式表明流行变体中存在B.1.1.318。使用Allplex SARS-CoV-2检测试剂盒、Viasure SARS-CoV-2实时检测试剂盒和GeneFinder COVID-19 Plus RealAmp试剂盒确定的SARS-CoV-2阳性样本,在核衣壳(N)基因扩增方面出现延迟或失败,对此进行了进一步调查。全基因组测序用于变体特征分析。计算了每个检测系统中N基因与其他基因扩增的平均循环阈值(Ct)值之间的差异,发现至少为14个循环。全基因组测序显示,所有N基因缺失样本都含有B.1.1.318变体。所有分离株在N基因中都有三个非同义突变,导致四个氨基酸变化(R203K、G204R、A208G、Met234I)。尽管基于病毒基因扩增失败来鉴定SARS-CoV-2变体时应谨慎,但这种模式可作为快速且经济高效筛查的基础,作为特定变体社区传播的指标,后续需要通过测序进行验证。